Trinity Biotech Plc (TRIB)

0.7454 +0.05 (+6.62%) USD  |  NASDAQ  |  Apr 17, 16:00
0.72 -0.03 (-3.41%) After-Hours: 20:00
More

Trinity Biotech SG&A Expense (Quarterly) : 6.429M for Sept. 30, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for TRIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Amarin Corp. Plc 18.95M
DBV Technologies SA 12.79M
Ascendis Pharma A/S 158.13M
Cellectis SA 4.798M
Akari Therapeutics Plc 2.138M